4//SEC Filing
Gray Nancy Ryan 4
Accession 0002001011-24-000054
CIK 0000886163other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 8:00 PM ET
Size
5.0 KB
Accession
0002001011-24-000054
Insider Transaction Report
Form 4
Gray Nancy Ryan
Director
Transactions
- Sale
Common Stock
2024-05-09$83.20/sh−934$77,713→ 5,633 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.1100 to $83.2650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001714949
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 8:00 PM ET
- Size
- 5.0 KB